Harte Group
Business Services · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 N Franklin St Ste 203, Doylestown, Pe...Phone Number
(215) 766-2397Website
www.hartegroup.comRevenue
$24.2 MillionIndustry
About Harte Group
Harte Group specializes in providing efficient and cost-effective solutions for clinical research, leveraging decades of experience in pharmaceutical and biotechnology development. They offer a range of services including clinical operations support, vendor oversight, patient recruitment, and site management for drug trials. Their intended clients are pharmaceutical and biotechnology companies looking to bring new products to market while managing budgets and operational challenges. With a focus on bridging gaps in clinical research, Harte Group aims to enhance the success of their clients' programs and improve patient outcomes.Explore more
SIC Code 87,874NAICS Code 54,541Show moreHarte Group Org Chart
Compare Similar Companies to Harte Group
Compare insights from companies similar to Harte Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$42.4M
51-200
Private
-
2004
TJ
Tsira JibladzeSenior Project Manager & Head of Country International Clinical Trials & Manager, Clinical Trials Regulatory
Harte Group Tech Stack
A closer look at the technologies used by Harte Group
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Harte Group
Sign Up For FreeTo access detailed company insights
Harte Group specializes in providing efficient and cost-effective solutions for clinical research, leveraging decades of experience in pharmaceutical and biotechnology development. They offer a range of services including clinical operations support, vendor oversight, patient recruitment, and site management for drug trials. Their intended clients... Read More